Tilray Brands, Inc. (FRA:2HQ0)
Germany · Delayed Price · Currency is EUR | Market Cap | 868.86M |
| Revenue (ttm) | 722.11M |
| Net Income (ttm) | -1.82B |
| Shares Out | n/a |
| EPS (ttm) | -17.98 |
| PE Ratio | n/a |
| Forward PE | 21.02 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,633 |
| Average Volume | 7,901 |
| Open | 8.06 |
| Previous Close | 8.21 |
| Day's Range | 7.92 - 8.06 |
| 52-Week Range | 2.99 - 19.50 |
| Beta | n/a |
| RSI | 41.93 |
| Earnings Date | Jan 8, 2026 |
About Tilray Brands
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the c... [Read more]
Financial Performance
In 2025, Tilray Brands's revenue was $821.31 million, an increase of 4.10% compared to the previous year's $788.94 million. Losses were -$2.19 billion, 792.6% more than in 2024.
Financial numbers in USD Financial StatementsNews
This Beaten-Down Stock Just Posted Record Revenue. Is It Finally Time to Buy?
Tilray's latest financial results were fairly strong. The company could have a large market opportunity in the U.S. However, Tilray still faces significant challenges.
How to play cannabis stocks in 2026
President Trump's executive order to reschedule marijuana is one of the many things cannabis investors will be watching in 2026. AdvisorShares portfolio manager Dan Ahrens, who manages the firm's Pure...
3 Canadian Marijuana Stocks For Investors In 2026
The cannabis industry is set to reach new horizons in 2026. More companies are coming together to take the industry to a level yet to be seen. With bigger and better partnerships taking effect this ye...
International Cannabis Expansion Gives Tilray Positive 2026 Outlook
Tilray reported financial performance for Q2-2026 with international sales driving growth. Tilray remains undervalued after its reverse split and after the rally over rescheduling subsided. Tilray for...
Marijuana industry taking fight against Wall Street blockades straight to Trump
Bankers have argued that Pot Inc.'s far-bigger prospective business – recreational use that would include the smoking of joints and ingesting high-inducing gummies – wasn't specifically addressed by t...
Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript
Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript
Why Tilray Brands Stock Is Rising in After-Hours Trading
Tilray reported Q2 2026 financial results after the bell today. The company reported improvements at the top and bottom of the income statement compared to the same period last year.
Tilray Stock Fires Up After Record Q2 Earnings: Here's Why
Tilray Brands, Inc.. (NASDAQ: TLRY) shares climbed in Thursday's extended trading after the company released its second-quarter earnings report, beating expectations on the top and bottom lines.
Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance
International Medical Cannabis Revenue Increases 36%; Canadian Adult-Use Cannabis Revenue Grows 6% Tilray Pharma Achieves Record Quarterly Revenue U.S. Federal Cannabis Rescheduling Expected to Unlock...
Top Wall Street Forecasters Revamp Tilray Brands Expectations Ahead Of Q2 Earnings
Tilray Brands, Inc. (NASDAQ: TLRY) will release earnings results for its second quarter after the closing bell on Thursday, Jan. 8, 2025.
Tilray Q2: High Hopes or Harsh Reality?
As Canadian cannabis king Tilray Brands, Inc. (NASDAQ: TLRY) prepares to report its fiscal Q2 2026 results on Thursday, the company stands at a crossroads.
Best Canadian Cannabis Stocks to Watch Entering 2026
The cannabis industry continues to evolve as investors look toward 2026 with renewed optimism. Canadian cannabis companies remain at the center of global expansion. They benefit from strong medical pr...
Tilray stock forms a risky pattern: Jan. 8 will be key
Tilray stock price has been highly volatile in the past few months as investors focused on Donald Trump's cannabis reclassification efforts and its implications. It surged from $3.59 in June to a high...
Tilray Brands Expands Dry January Offerings with Zero-Proof Spirits, Non-Alcoholic Beers and Hemp-Derived THC Beverages
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellnes...
Top Stocks With Earnings This Week: Tilray, Applied Digital and More
As the first full week of 2026 kicks off, the earnings calendar features a mix of early reports in the cannabis, AI infrastructure and consumer goods sectors.
Enhance Your Dry January with Mindful Sipping: Try Tilray's Mollo and XMG Cannabis Beverages
TORONTO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellnes...
How Long Will the Cannabis Stock Rally Last?
Cannabis stocks have had significant momentum due to positive regulatory changes in the U.S. However, this momentum is likely to be relatively short-lived. These 10 Stocks Could Mint the Next Wave of ...
Trump Is Warming to Cannabis, but Investors Aren't Impressed
Stocks took a surprise tumble after the White House moved to reclassify marijuana as a less dangerous drug.
2 Marijuana Stocks To Watch For Better Investing In 2026
The cannabis industry continues evolving into a bigger and more regulated global market. Legalization trends are expanding across the United States and international regions. This growth fuels long-te...
I Was Right: President Trump Will Legalize Marijuana in 2026
President Trump has ordered that marijuana be reclassified as a Schedule III drug. The move doesn't fully legalize marijuana -- yet -- but it may foreshadow changes to come.
3 Marijuana Stocks To Watch In 2026
The cannabis industry is entering another critical growth phase, positioning 2026 as a potentially pivotal year. Particularly for long-term investors looking to make a profit with marijuana stocks. Af...
Marijuana Stocks To Watch After The Holidays
In 2026, the impact of cannabis rescheduling is expected to be far more visible in marijuana stock performance. Much more than in the initial announcement of cannabis becoming a Class 3 substance. Whi...
Is Tilray Stock's 25% Drop An Opportunity Or Trap?
Tilray Brands (TLRY) stock has declined by 25.3% in under a month, decreasing from $13.94 on 16th Dec, 2025 to $10.53 currently. Is it time to purchase this dip?
This Stock Has Almost Tripled in 6 Months. Here's What Investors Need to Watch Next
Tilray's shares have soared since mid-2025, driven by expectations of cannabis reclassification in the U.S. These expectations have now become a reality, and they will have an impact on pot growers in...
President Trump Just Reclassified Marijuana. Are Green Thumb, Tilray, and Trulieve Stocks No-Brainer Buys?
Trump's executive order to reclassify marijuana from Schedule I to Schedule III recognized the valid medical uses of the drug. The move could impact cannabis companies in several ways, including allow...